Edition:
United States

Nightstar Therapeutics PLC (NITE.OQ)

NITE.OQ on NASDAQ Stock Exchange Global Select Market

13.62USD
14 Dec 2017
Change (% chg)

$0.16 (+1.19%)
Prev Close
$13.46
Open
$13.59
Day's High
$13.86
Day's Low
$13.02
Volume
4,078
Avg. Vol
35,408
52-wk High
$24.70
52-wk Low
$12.49

Chart for

About

Nightstar Therapeutics PLC, formerly Nightstar Therapeutics Limited, is a clinical-stage gene therapy company. The Company is focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness. The Company is developing a... (more)

Overall

Beta: --
Market Cap(Mil.): $383.86
Shares Outstanding(Mil.): 28.10
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 196.13 16.04
EPS (TTM): -- -- --
ROI: -- -11.69 35.70
ROE: -- -36.44 15.40

BRIEF-Nightstar Therapeutics announces pricing of initial public offering

* Pricing initial public offering of 5.4 million American Depositary Shares at $14 per ADS for total gross proceeds of about $75 million Source text for Eikon: Further company coverage:

Sep 27 2017

Earnings vs. Estimates